We are live on
!
Find out more
iBio
IBIO
IBIO
16 hedge funds and large institutions have $1.01M invested in iBio in 2017 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 5 increasing their positions, 1 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
400% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 1
0% more ownership
Funds ownership: 0% → 0% (+0%)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
6% less funds holding
Funds holding: 17 → 16 (-1)
13% less capital invested
Capital invested by funds: $1.16M → $1.01M (-$151K)
Holders
16
Holders Change
-1
Holders Change %
-5.88%
% of All Funds
0.4%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
5
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
VF
Virtu Financial
New York
|
+$37.1K |
| 2 |
TSS
Two Sigma Securities
New York
|
+$29K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$16.1K |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$3.22K |
| 5 |
BlackRock
New York
|
+$1.61K |
Top Sellers
| 1 |
Citadel Advisors
Miami,
Florida
|
-$22K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$11.3K |
